| P50 | author | Sepideh Khaksar | Q64010268 |
| P2093 | author name string | Mohammad Reza Bigdeli | |
| P2860 | cites work | Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia | Q49021460 |
| | AChE-stained horizontal sections of the rat brain in stereotaxic coordinates | Q58592230 |
| | Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants | Q24685540 |
| | NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review | Q26770760 |
| | Pathobiology of ischaemic stroke: an integrated view | Q28141682 |
| | Reversible middle cerebral artery occlusion without craniectomy in rats | Q28268048 |
| | Stroke | Q28279570 |
| | Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement | Q28394506 |
| | Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol | Q33869556 |
| | Tumor necrosis factor signaling. | Q34185821 |
| | Regulation of proliferation, survival and apoptosis by members of the TNF superfamily | Q34269354 |
| | PACAP38 differentially effects genes and CRMP2 protein expression in ischemic core and penumbra regions of permanent middle cerebral artery occlusion model mice brain | Q34358768 |
| | Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism | Q34413146 |
| | Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance | Q34576215 |
| | Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. | Q34707322 |
| | Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress | Q34898890 |
| | Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes | Q35070770 |
| | The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat | Q35225934 |
| | Mitochondrial respiratory chain and free radical generation in stroke. | Q36300732 |
| | Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression | Q36358055 |
| | Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications | Q36736801 |
| | NF-kappaB signaling in cerebral ischemia | Q37233479 |
| | Cell adhesion molecules and ischemic stroke | Q37282898 |
| | Inflammatory mechanisms in ischemic stroke: therapeutic approaches | Q37634142 |
| | Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. | Q39881941 |
| | Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement | Q40313822 |
| | Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury | Q42518443 |
| | The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. | Q43245497 |
| | Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. | Q43870741 |
| | High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration | Q43984102 |
| | Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils | Q44506288 |
| | Nuclear factor-kappaB contributes to infarction after permanent focal ischemia | Q44779510 |
| | The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice | Q45266148 |
| | A semiautomated method for measuring brain infarct volume. | Q45954002 |
| | Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets. | Q46446532 |
| | Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy | Q46515228 |
| | Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue | Q48181282 |
| | Cerebral impedance and neurological outcome following a mild or severe hypoxic/ischemic episode in neonatal piglets | Q48344594 |
| | Examination of sensorimotor performance following middle cerebral artery occlusion in rats | Q48392122 |
| | Recombinant human tumor necrosis factor alpha constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets | Q48395233 |
| | The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells | Q48475306 |
| | Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function | Q48485686 |
| P433 | issue | 13-14 | |
| P921 | main subject | cerebral infarction | Q1209150 |
| | TNF | Q18032037 |
| | cannabidiol | Q422917 |
| | cannabinoids | Q422936 |
| P304 | page(s) | 1932-1943 | |
| P577 | publication date | 2017-09-05 | |
| P1433 | published in | Brain Injury | Q4955769 |
| P1476 | title | Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia | |
| P478 | volume | 31 | |